Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood
S Kariotis, E Jammeh, EM Swietlik, JA Pickworth… - Nature …, 2021 - nature.com
… 13 studies have described diagnostic and prognostic biomarkers that add to our increasing
… into multiple distinct transcriptomic subgroups that associate with different survival properties…
… into multiple distinct transcriptomic subgroups that associate with different survival properties…
Identification of common signatures in idiopathic pulmonary fibrosis and lung cancer using gene expression modeling
D Leng, J Yi, M Xiang, H Zhao, Y Zhang - BMC cancer, 2020 - Springer
… The gene expression profiles of patients with lung disorders were distinct from those of the
healthy controls, and 11,926 genes were significantly differentially expressed with P < 0.05 (…
healthy controls, and 11,926 genes were significantly differentially expressed with P < 0.05 (…
Biomarkers of cellular senescence in idiopathic pulmonary fibrosis
Z Aversa, EJ Atkinson, EM Carmona, TA White… - Respiratory …, 2023 - Springer
… in the current study was based on diverse components of the SASP commonly observed in
cell… While individual components of our biomarker panel are certainly not unique to senescent …
cell… While individual components of our biomarker panel are certainly not unique to senescent …
Decreased peak expiratory flow rate associated with mortality in idiopathic pulmonary fibrosis: A preliminary report
K Fujita, H Ohkubo, A Nakano… - Chronic Respiratory …, 2022 - journals.sagepub.com
… In conclusion, a decrease in PEFR after 6 months could be a novel and useful prognostic …
Where there are more than one item, you can scroll through each tab to see each separate …
Where there are more than one item, you can scroll through each tab to see each separate …
Biomarkers and early treatment of idiopathic pulmonary fibrosis
JA Kropski - The Lancet Respiratory Medicine, 2019 - thelancet.com
… The study population was unique compared with other idiopathic pulmonary fibrosis trials …
in idiopathic pulmonary fibrosis trials seems necessary. Currently recognised prognostic …
in idiopathic pulmonary fibrosis trials seems necessary. Currently recognised prognostic …
Integrative analysis of lung molecular signatures reveals key drivers of systemic sclerosis-associated interstitial lung disease
SM Jung, KS Park, KJ Kim - Annals of the Rheumatic Diseases, 2022 - ard.bmj.com
… Although SSc-ILD shares many pathogenic features with idiopathic pulmonary fibrosis (IPF), …
common and distinct pathways involved in the four disease groups. The composition of key …
common and distinct pathways involved in the four disease groups. The composition of key …
Progression of fibrosing interstitial lung disease
AW Wong, CJ Ryerson, SA Guler - Respiratory research, 2020 - Springer
… medications in patients with idiopathic pulmonary fibrosis (IPF) and … important given the
worse prognosis in IPF compared to … effect in pulmonary fibrosis caused by a variety of different …
worse prognosis in IPF compared to … effect in pulmonary fibrosis caused by a variety of different …
Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis
Y Tanaka, Y Suzuki, H Hasegawa, K Yokomura… - Respiratory …, 2022 - Springer
… images, providing accurate lung volume (LV) measurements in different lung lobes. … 3D-CT
LV of the lower lobes had no prognostic impact, while the standardised 3D-CT LV of the …
LV of the lower lobes had no prognostic impact, while the standardised 3D-CT LV of the …
Pleuroparenchymal fibroelastosis. A review of clinical, radiological, and pathological characteristics
… idiopathic pulmonary fibrosis, patients with chronic obstructive … a negative prognostic impact
specifically attributable to UIP (… PPFE and a separate fibrotic lung disease such as UIP fare …
specifically attributable to UIP (… PPFE and a separate fibrotic lung disease such as UIP fare …
From cigarette smoking to Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis. Why?
D Biondini - 2019 - research.unipd.it
… Moreover, we also explored whether different lung tissue inflammatory profiles may impact
on the response to Pirfenidone treatment, which exerts also an anti-inflammatory effect. Finally…
on the response to Pirfenidone treatment, which exerts also an anti-inflammatory effect. Finally…